Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Autoantibody to PL-12 (Anti-Alanyl-tRNA Synthetase) in an African American Girl with Juvenile Dermatomyositis and Resolution of Interstitial Lung Disease

PATRICIA VEGA, MARIA IBARRA, ADRIENNE PRESTRIDGE and LAUREN M. PACHMAN
The Journal of Rheumatology February 2011, 38 (2) 394-395; DOI: https://doi.org/10.3899/jrheum.100608
PATRICIA VEGA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA IBARRA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ADRIENNE PRESTRIDGE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAUREN M. PACHMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pachman@northwestern.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Feldman BM,
    2. Rider LG,
    3. Reed AM,
    4. Pachman LM
    . Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008;371:2201–12.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Hengstman GJ,
    2. van Engelen BG,
    3. Vree Egberts WT,
    4. van Venrooij WJ
    . Myositis-specific autoantibodies: Overview and recent developments. Curr Opin Rheumatol 2001;13:476–82.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Rider LG,
    2. Miller FW,
    3. Targoff IN,
    4. Sherry DD,
    5. Samayoa E,
    6. Lindahl M,
    7. et al.
    A broadened spectrum of juvenile myositis-specific autoantibodies in children. Arthritis Rheum 1994;37:1534–8.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Christen-Zaechs S,
    2. Seshadri R.,
    3. Sundberg J,
    4. Paller AS,
    5. Pachman LM
    . Juvenile dermatomyositis: Persistent association of nailfold capillaroscopy changes and skin involvement over 36 months with duration of untreated disease. Arthritis Rheum 2008;58:571–6.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Targoff IN,
    2. Arnett FC
    . Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990;88:241–51.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Pachman LM,
    2. Geraci N,
    3. Morgan G,
    4. Daniels B,
    5. Seshadri R,
    6. Sullivan D,
    7. et al.
    Absolute number of circulating CD3-CD56+/CD16+ natural killer (NK) cells, a potential biomarker of disease activity in juvenile dermatomyositis (JDM) [abstract]. Arthritis Rheum 2008;58 Suppl:S225.
    OpenUrl
  7. 7.↵
    1. Rouster-Stevens KA,
    2. Gursahaney A,
    3. Ngai K-L,
    4. Daru JA,
    5. Pachman LM
    . Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis Care Res 2008;59:222–66.
    OpenUrlCrossRef
  8. 8.↵
    1. Rouster-Stevens KA,
    2. Morgan GA,
    3. Wang D,
    4. Pachman LM
    . Mycophenolate mofetil, a possible therapeutic agent for children with juvenile dermatomyositis. Arthritis Care Res 2010;62:1446–51.
    OpenUrlCrossRef
  9. 9.↵
    1. Love LA,
    2. Leff RL,
    3. Fraser DD,
    4. Targoff IN,
    5. Dalakas M,
    6. Plotz PH,
    7. et al.
    A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360–74.
    OpenUrlPubMed
  10. 10.↵
    1. Kalluri M,
    2. Sahn SA,
    3. Oddis CV,
    4. Gharib SL,
    5. Christopher-Stine L,
    6. Danoff SK,
    7. et al.
    Clinical profile of anti-PL-12 autoantibody: Cohort study and review of the literature. Chest 2009;135:1550–6.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Pachman LM,
    2. Cooke N
    . Juvenile dermatomyositis: A clinical and immunological study. J Pediatr 1980;96:226–34.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Huber AM,
    2. Feldman BM,
    3. Rennebohm RM,
    4. Hicks JE,
    5. Lindsley CB,
    6. Perez MD,
    7. et al.
    Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50:1595–603.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Guzman J,
    2. Petty RE,
    3. Malleson PN
    . Monitoring disease activity in juvenile dermatomyositis: The role of von Willebrand factor and muscle enzymes. J Rheumatol 1994;21:739–43.
    OpenUrlPubMed
  14. 14.↵
    1. Ansell BA,
    2. Miller JJ III.,
    3. Pachman LM,
    4. Sullivan DB
    . Controversies in juvenile dermatomyositis. J Rheumatol 1990;17:1–6.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 38, Issue 2
1 Feb 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Autoantibody to PL-12 (Anti-Alanyl-tRNA Synthetase) in an African American Girl with Juvenile Dermatomyositis and Resolution of Interstitial Lung Disease
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Autoantibody to PL-12 (Anti-Alanyl-tRNA Synthetase) in an African American Girl with Juvenile Dermatomyositis and Resolution of Interstitial Lung Disease
PATRICIA VEGA, MARIA IBARRA, ADRIENNE PRESTRIDGE, LAUREN M. PACHMAN
The Journal of Rheumatology Feb 2011, 38 (2) 394-395; DOI: 10.3899/jrheum.100608

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Autoantibody to PL-12 (Anti-Alanyl-tRNA Synthetase) in an African American Girl with Juvenile Dermatomyositis and Resolution of Interstitial Lung Disease
PATRICIA VEGA, MARIA IBARRA, ADRIENNE PRESTRIDGE, LAUREN M. PACHMAN
The Journal of Rheumatology Feb 2011, 38 (2) 394-395; DOI: 10.3899/jrheum.100608
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • IgG4-Related Disease With Testicular Involvement: Association or Coincidence?
  • The Use of Tofacitinib Has a Potential Effect on Improving the Outcomes of Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease
  • Considerable Uncertainty About the Burden of Gout in the Middle East and North Africa Region
Show more Letters

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire